Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Roleca-Wacholder 100 mg
- Development stage
- Unknown
- Lead developer
- Roleca Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
**Roleca-Wacholder 100 mg** is a German nonprescription herbal medicinal product supplied as an oral soft capsule containing 100 mg of juniper berry oil from *Juniperus communis* L. It is used for dyspeptic digestive complaints, including mild gastrointestinal cramping, flatulence, and postprandial fullness. The product was evaluated in a randomized, double-blind, placebo-controlled Phase IV study in adults with functional dyspepsia. Juniper oil is a chemically complex botanical essential-oil preparation; its digestive effects are not attributable to a single clinically established molecular target.
- Brand names
- Roleca-Wacholder 100 mgRoleca-Wacholder100 mgRoleca-Wacholder-100 mg
- Other names
- Roleca Juniper 100 mgRoleca Wacholder 100 mgRoleca-Wacholderöl 100 mg
Beyond the preview
Go deeper on Roleca-Wacholder 100 mg.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Roleca-Wacholder 100 mg.